Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Gomez-Ramos, Albertoa; b | Picher, Angel J.c | García, Esthera; b | Garrido, Patriciac | Hernandez, Felixa; b | Soriano, Eduardoa; d; e; f; * | Avila, Jesúsa; b; *
Affiliations: [a] Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain | [b] Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain | [c] Sygnis S.L.U. Parque Científico de Madrid. Cantoblanco, Madrid, Spain | [d] Department of Cell Biology and Institute of Neurosciences, University of Barcelona, Barcelona, Spain | [e] Vall d’Hebrón Institut de Recerca (VHIR), Barcelona, Spain | [f] ICREA Academia, Barcelona, Spain
Correspondence: [*] Correspondence to: Jesús Avila, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, Spain. Tel.: +34 911964564; Fax. +34 911964420; E-mail: [email protected]. and Eduardo Soriano, Department of Cell Biology, University of Barcelona, 08028 Barcelona, Spain. Tel.: +34 934037117; E-mail: [email protected].
Abstract: Next-generation sequencing techniques and genome-wide association study analyses have provided a huge amount of data, thereby enabling the identification of DNA variations and mutations related to disease pathogenesis. New techniques and software tools have been developed to improve the accuracy and reliability of this identification. Most of these tools have been designed to discover and validate single nucleotide variants (SNVs). However, in addition to germ-line mutations, human tissues bear genomic mosaicism, which implies that somatic events are present only in low percentages of cells within a given tissue, thereby hindering the validation of these variations using standard genetic tools. Here we propose a new method to validate some of these somatic mutations. We combine a recently developed software with a method that cuts DNA by using restriction enzymes at the sites of the variation. The non-cleaved molecules, which bear the SNV, can then be amplified and sequenced using Sanger’s technique. This procedure, which allows the detection of alternative alleles present in as few as 10% of cells, could be of value for the identification and validation of low frequency somatic events in a variety of tissues and diseases.
Keywords: Alzheimer’s disease, identification of nucleotide variations, Sanger sequencing, somatic mutations, Virmid software
DOI: 10.3233/JAD-161053
Journal: Journal of Alzheimer's Disease, vol. 56, no. 3, pp. 977-990, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]